Calidi Biotherapeutics, Inc. (CLDI)

Cost of Revenue

$426.00K

TTM · Period ending: · USD

CLDI logo

CLDI Cost of Revenue

Latest reported$426.00K
CLDI TTM Cost of Revenue ($64.00K → $426.00K)
High-resolution chart · PNG

CLDI cost of revenue history

Trailing twelve months (TTM) · USD. Each value covers four complete reported quarters.

Calidi Biotherapeutics, Inc. Cost of Revenue — Trailing twelve months (TTM) (USD)
Period endingCost of Revenue (USD)
426,000
426,000
0
393,000
393,000
393,000
767,000
738,000
838,000
838,000
464,000
100,000
0
0
14,000
64,000
64,000
64,000
Data is provided for informational purposes only and does not constitute investment advice. Past performance is not indicative of future results.